Su Golder1, Gill Norman2, Yoon K Loke3. 1. Department of Health Sciences, University of York, York, YO10 5DD, UK. 2. School of Nursing, Midwifery & Social Work, University of Manchester, Room 5.328, Jean McFarlane Building, Oxford Road, Manchester, M13 9PL, UK. 3. Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK.
Abstract
AIM: The aim of this review was to summarize the prevalence, frequency and comparative value of information on the adverse events of healthcare interventions from user comments and videos in social media. METHODS: A systematic review of assessments of the prevalence or type of information on adverse events in social media was undertaken. Sixteen databases and two internet search engines were searched in addition to handsearching, reference checking and contacting experts. The results were sifted independently by two researchers. Data extraction and quality assessment were carried out by one researcher and checked by a second. The quality assessment tool was devised in-house and a narrative synthesis of the results followed. RESULTS: From 3064 records, 51 studies met the inclusion criteria. The studies assessed over 174 social media sites with discussion forums (71%) being the most popular. The overall prevalence of adverse events reports in social media varied from 0.2% to 8% of posts. Twenty-nine studies compared the results from searching social media with using other data sources to identify adverse events. There was general agreement that a higher frequency of adverse events was found in social media and that this was particularly true for 'symptom' related and 'mild' adverse events. Those adverse events that were under-represented in social media were laboratory-based and serious adverse events. CONCLUSIONS: Reports of adverse events are identifiable within social media. However, there is considerable heterogeneity in the frequency and type of events reported, and the reliability or validity of the data has not been thoroughly evaluated.
AIM: The aim of this review was to summarize the prevalence, frequency and comparative value of information on the adverse events of healthcare interventions from user comments and videos in social media. METHODS: A systematic review of assessments of the prevalence or type of information on adverse events in social media was undertaken. Sixteen databases and two internet search engines were searched in addition to handsearching, reference checking and contacting experts. The results were sifted independently by two researchers. Data extraction and quality assessment were carried out by one researcher and checked by a second. The quality assessment tool was devised in-house and a narrative synthesis of the results followed. RESULTS: From 3064 records, 51 studies met the inclusion criteria. The studies assessed over 174 social media sites with discussion forums (71%) being the most popular. The overall prevalence of adverse events reports in social media varied from 0.2% to 8% of posts. Twenty-nine studies compared the results from searching social media with using other data sources to identify adverse events. There was general agreement that a higher frequency of adverse events was found in social media and that this was particularly true for 'symptom' related and 'mild' adverse events. Those adverse events that were under-represented in social media were laboratory-based and serious adverse events. CONCLUSIONS: Reports of adverse events are identifiable within social media. However, there is considerable heterogeneity in the frequency and type of events reported, and the reliability or validity of the data has not been thoroughly evaluated.
Authors: Adrian Benton; Lyle Ungar; Shawndra Hill; Sean Hennessy; Jun Mao; Annie Chung; Charles E Leonard; John H Holmes Journal: J Biomed Inform Date: 2011-07-26 Impact factor: 6.317
Authors: Jun J Mao; Annie Chung; Adrian Benton; Shawndra Hill; Lyle Ungar; Charles E Leonard; Sean Hennessy; John H Holmes Journal: Pharmacoepidemiol Drug Saf Date: 2013-01-16 Impact factor: 2.890
Authors: Gregory E Powell; Harry A Seifert; Tjark Reblin; Phil J Burstein; James Blowers; J Alan Menius; Jeffery L Painter; Michele Thomas; Carrie E Pierce; Harold W Rodriguez; John S Brownstein; Clark C Freifeld; Heidi G Bell; Nabarun Dasgupta Journal: Drug Saf Date: 2016-05 Impact factor: 5.606
Authors: Tiffany A Suragh; Smaragda Lamprianou; Noni E MacDonald; Anagha R Loharikar; Madhava R Balakrishnan; Oleg Benes; Terri B Hyde; Michael M McNeil Journal: Vaccine Date: 2018-08-29 Impact factor: 3.641
Authors: Su Golder; Robin Stevens; Karen O'Connor; Richard James; Graciela Gonzalez-Hernandez Journal: J Med Internet Res Date: 2022-04-29 Impact factor: 7.076
Authors: Mei Sheng Duh; Pierre Cremieux; Marc Van Audenrode; Francis Vekeman; Paul Karner; Haimin Zhang; Paul Greenberg Journal: Pharmacoepidemiol Drug Saf Date: 2016-09-07 Impact factor: 2.890
Authors: Charline Bour; Adrian Ahne; Susanne Schmitz; Camille Perchoux; Coralie Dessenne; Guy Fagherazzi Journal: J Med Internet Res Date: 2021-05-27 Impact factor: 5.428